Belite Bio, Inc Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Belite Bio, Inc (BLTE) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -0.10% for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-31
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.10% 20-F · filed 2026-03-31 | |
| 2024-12-31 | -0.42% 20-F · filed 2026-03-31 | |
| 2023-12-31 | -0.25% 20-F · filed 2026-03-31 | |
| 2022-12-31 | 0.44% 20-F · filed 2025-03-17 | -0.44% 20-F · filed 2023-03-31 |
| 2021-12-31 | 0.20% 20-F · filed 2024-03-12 | -0.20% 20-F · filed 2023-03-31 |
| 2020-12-31 | -0.26% 20-F · filed 2023-03-31 |